Building on four years of evidence gathering by the Study, the ACCISS team has created an online toolkit to provide national and international health policymakers and others with a better understanding of the underlying parameters that define universal access (and the lack thereof) to insulin for people living with type 1 and 2 diabetes in low- and middle-income countries (LMICs). They provide evidence and practical guidance related to access to insulin in LMICs, and give recommendations for stakeholders interested in improving access to insulin.

Visit the toolkit at

Access a Major Obstacle for One in Two People Using Insulin to Manage Type 2 Diabetes – An ACCISS Study paper published in The Lancet Diabetes and Endocrinology estimates that, between 2018 and 2030, the number of people with type 2 diabetes using insulin will rise to 79 million. But without improved availability and affordability, over half of those will face challenges in accessing this life-saving medicine. Read our press release.


Research Findings
Find out what our researchers are discovering about the global barriers to insulin access.



About the ACCISS Study 
Learn more about the ACCISS Study and why the issue of access to insulin is so critical.



Media Coverage & Press Statements
Be the first to get news, results and other information from the study.



Join the ACCISS Network
Be the first to get news, results and other information from the study.


Watch videos about topics relating to access to insulin and from our meetings and conferences.